Method for preparing optically active 1-aminoindan derivatives
US5639913A · kind A · utility
28Cited by
10References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 13, 1996 |
| Grant date | Jun 17, 1997 |
| Priority date | — |
| Expiry date | Sep 13, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel derivatives of 1-aminoindan and their salts are described. Optically active 1-aminoindan derivatives are prepared by reacting a N-benzyl analog of the desired compound with an enantiomer of mandelic acid. Parkinson's disease, dementia, epilepsy, convulsions, or seizures are treated by administering a compound of the formula: ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.